Jasper Therapeutics(JSPR),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community - To The Moon

At the request of the exchanges, the U.S./Hong Kong stock quotes are displayed on a 15-minute delay, download the APP to view the real-time quotes for free.

Close

JSPR Jasper Therapeutics

Market Closed 08-07 16:00:00 EDT

0.7095

+0.0634

+9.81%

盘后0.7022

-0.0073-1.03%

19:42 EDT

High0.7500	Low0.6501	Vol760.65K
Open0.6515	D1 Closing0.6461	Amplitude15.46%
Mkt Cap23.61M	Tradable Cap19.32M	Total Shares33.27M
T/O538.53K	T/O Rate2.79%	Tradable Shares27.23M
P/B--	ROE--	EPS0.00
52wk High--	52wk Low--	P/E--
Dividend--	Div.Yield--	ROA--

Loading ...

{"stockData":{"symbol":"JSPR","market":"US","secType":"STK","nameCN":"Jasper Therapeutics","latestPrice":0.7095,"timestamp":1786132800000,"preClose":0.6461,"halted":0,"volume":760645,"hourTrading":{"tag":"盘后","latestPrice":0.7022,"preClose":0.7095,"latestTime":"19:42 EDT","volume":3458,"amount":2440.831,"timestamp":1786146163441,"change":-0.0073,"changeRate":-0.010289,"amplitude":0.011839},"delay":0,"changeRate":0.09812722488778829,"floatShares":27227911,"shares":33274600,"eps":-2.469679,"marketStatus":"Market Closed","change":0.0634,"latestTime":"08-07 16:00:00 EDT","open":0.6515,"high":0.75,"low":0.6501,"amount":538533.3892265001,"amplitude":0.15462,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-2.469679,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Mkt","tradingStatus":1,"beginTime":1786348800000},"marketStatusCode":7,"adr":0,"exchange":"NASDAQ","adjPreClose":0.6461,"preHourTrading":{"tag":"盘前","latestPrice":0.637,"preClose":0.6461,"latestTime":"09:25 EDT","volume":880,"amount":540.2701920000001,"timestamp":1786109100168,"change":-0.0091,"changeRate":-0.014085,"amplitude":0.041325},"postHourTrading":{"tag":"盘后","latestPrice":0.7022,"preClose":0.7095,"latestTime":"19:42 EDT","volume":3458,"amount":2440.831,"timestamp":1786146163441,"change":-0.0073,"changeRate":-0.010289,"amplitude":0.011839},"volumeRatio":1.4902119284241218,"impliedVol":1.7186,"impliedVolPercentile":0.6574},"requestUrl":"/m/hq/s/JSPR","defaultTab":"news","newsList":[{"id":"2657164293","title":"Jasper Therapeutics, Inc. Expected to Post a Loss of 35 Cents a Share - Earnings Preview","url":"https://stock-news.laohu8.com/highlight/detail?id=2657164293","media":"Reuters","labels":["preview"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2657164293?lang=en_us&edition=fundamental","pubTime":"2026-08-07 23:01","pubTimestamp":1786114909,"startTime":"0","endTime":"0","summary":"Jasper Therapeutics, Inc. <JSPR.OQ> expected to post a loss of35cents a share - Earnings PreviewJasper Therapeutics, Inc.JSPR.OQJSPR.Ois expected to  show no change in quarterly revenue when it report","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260807:nL8N4441SU:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"preview","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["JSPR","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2657569766","title":"Jasper Therapeutics Halts Briquilimab Extension Study in Chronic Urticaria: What Investors Should Know","url":"https://stock-news.laohu8.com/highlight/detail?id=2657569766","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2657569766?lang=en_us&edition=fundamental","pubTime":"2026-08-07 00:30","pubTimestamp":1786033831,"startTime":"0","endTime":"0","summary":"Jasper Therapeutics, Inc. ($JSPR) announced an update on their ongoing clinical study. This Phase 2 extension study, titled “Open-Label Extension S...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/jasper-therapeutics-halts-briquilimab-extension-study-in-chronic-urticaria-what-investors-should-know?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/jasper-therapeutics-halts-briquilimab-extension-study-in-chronic-urticaria-what-investors-should-know?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4139","ISBC","JSPR","BK4211"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2657656973","title":"JSPR Completes Briquilimab Trial In Chronic Hives, Setting Up Next Risk–Reward Catalyst","url":"https://stock-news.laohu8.com/highlight/detail?id=2657656973","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2657656973?lang=en_us&edition=fundamental","pubTime":"2026-08-07 00:30","pubTimestamp":1786033820,"startTime":"0","endTime":"0","summary":"Jasper Therapeutics, Inc. ($JSPR) announced an update on their ongoing clinical study. Jasper Therapeutics, Inc. (JSPR) has completed a Phase 1b/2a...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/jspr-completes-briquilimab-trial-in-chronic-hives-setting-up-next-risk-reward-catalyst?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/jspr-completes-briquilimab-trial-in-chronic-hives-setting-up-next-risk-reward-catalyst?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4139","JSPR"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2656001563","title":"Jasper Therapeutics Shareholders Back Board, Auditors, Pay Plan","url":"https://stock-news.laohu8.com/highlight/detail?id=2656001563","media":"TIPRANKS","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2656001563?lang=en_us&edition=fundamental","pubTime":"2026-08-04 06:31","pubTimestamp":1785796268,"startTime":"0","endTime":"0","summary":"An update from Jasper Therapeutics ( ($JSPR) ) is now available. On July 31, 2026, Jasper Therapeutics, Inc. held its 2026 Annual Meeting of Stockh...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/jasper-therapeutics-shareholders-back-board-auditors-pay-plan?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/jasper-therapeutics-shareholders-back-board-auditors-pay-plan?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4139","JSPR"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2656302940","title":"Jasper Therapeutics Holds Annual Stockholders Meeting; 75% of Shares Represented","url":"https://stock-news.laohu8.com/highlight/detail?id=2656302940","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2656302940?lang=en_us&edition=fundamental","pubTime":"2026-08-04 04:55","pubTimestamp":1785790552,"startTime":"0","endTime":"0","summary":"Jasper Therapeutics holds annual stockholders meeting; 75% of shares representedJasper Therapeutics held its annual shareholder meeting on July 31, 2026.Shareholders selected two Class II directors to","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260803:nNDL84d9WC:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","JSPR"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2653791200","title":"Jasper Therapeutics COO Matthew E. Ros Files Initial Beneficial Ownership Statement","url":"https://stock-news.laohu8.com/highlight/detail?id=2653791200","media":"Reuters","labels":["executive","shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2653791200?lang=en_us&edition=fundamental","pubTime":"2026-07-23 07:11","pubTimestamp":1784761873,"startTime":"0","endTime":"0","summary":"Jasper Therapeutics COO Matthew E. Ros files initial beneficial ownership statementJasper Therapeutics COO Matthew E. Ros reported stock options for 103,204 voting common shares at USD 0.01.Disclaimer","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260722:nNDL85PZwl:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive,shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","JSPR"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2653244050","title":"Jasper Therapeutics Director Patrick J. Crutcher Files Initial Beneficial Ownership Statement","url":"https://stock-news.laohu8.com/highlight/detail?id=2653244050","media":"Reuters","labels":["executive","shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2653244050?lang=en_us&edition=fundamental","pubTime":"2026-07-21 08:38","pubTimestamp":1784594319,"startTime":"0","endTime":"0","summary":"Jasper Therapeutics director Patrick J. Crutcher files initial beneficial ownership statementJasper Therapeutics director Patrick J. Crutcher reported 518,331 voting common shares in an initial Form 3","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260721:nNDL25W8f7:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive,shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","JSPR"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2652440203","title":"Jasper Therapeutics Completes Kira Acquisition and PIPE Financing","url":"https://stock-news.laohu8.com/highlight/detail?id=2652440203","media":"TIPRANKS","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2652440203?lang=en_us&edition=fundamental","pubTime":"2026-07-17 18:32","pubTimestamp":1784284320,"startTime":"0","endTime":"0","summary":"An announcement from Jasper Therapeutics ( ($JSPR) ) is now available. On July 16, 2026, Jasper Therapeutics completed an all-stock acquisition of ...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/jasper-therapeutics-completes-kira-acquisition-and-pipe-financing?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/jasper-therapeutics-completes-kira-acquisition-and-pipe-financing?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4139","PIPE","JSPR"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2652942717","title":"Jasper Therapeutics Posts Investor Presentation on Kira Merger, PIPE Financing and Immunology Pipeline Strategy","url":"https://stock-news.laohu8.com/highlight/detail?id=2652942717","media":"Reuters","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2652942717?lang=en_us&edition=fundamental","pubTime":"2026-07-17 05:22","pubTimestamp":1784236965,"startTime":"0","endTime":"0","summary":"Jasper Therapeutics posts investor presentation on Kira merger, PIPE financing and immunology pipeline strategyJasper outlined a merger with Kira Pharmaceuticals in an all-stock deal, paired with a US","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260716:nNDL50nDLg:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","JSPR"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2652944427","title":"Jasper Therapeutics Completes Acquisition of Kira Pharmaceuticals in All-stock Deal","url":"https://stock-news.laohu8.com/highlight/detail?id=2652944427","media":"Reuters","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2652944427?lang=en_us&edition=fundamental","pubTime":"2026-07-17 05:15","pubTimestamp":1784236521,"startTime":"0","endTime":"0","summary":"Jasper Therapeutics completes acquisition of Kira Pharmaceuticals in all-stock dealJasper Therapeutics completed an all-stock acquisition of complement-therapy developer Kira Pharmaceuticals, forming ","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260716:nNDL8RZvFV:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00BKPKM429.USD","LU0314104364.USD","BCDF","IE00BN0W2T93.GBP","IE00BN0W2W23.USD","IE00BN0W2V16.EUR","BK4112","SG9999014005.SGD","IE00B3QW5Z07.USD","BK4585","BK4588","IE00BGHQF748.EUR","JSPR","IE00B64PRP62.GBP","LU2210149790.SGD","LU2095319765.USD","BK4139","SG9999014021.USD","LU2210150020.SGD","NDAQ","SG9999014039.USD","SG9999014013.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2652948427","title":"Jasper Therapeutics - Announces $132 Mln Private Placement of Convertible Preferred Stock","url":"https://stock-news.laohu8.com/highlight/detail?id=2652948427","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2652948427?lang=en_us&edition=fundamental","pubTime":"2026-07-17 05:15","pubTimestamp":1784236500,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260716:nTUAB2R19J:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","JSPR"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2652427945","title":"Jasper Therapeutics Announces Merger with Kira Pharmaceuticals","url":"https://stock-news.laohu8.com/highlight/detail?id=2652427945","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2652427945?lang=en_us&edition=fundamental","pubTime":"2026-07-17 05:15","pubTimestamp":1784236500,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260716:nTUAB2R19J:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","JSPR"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2652342794","title":"Jasper Therapeutics - Combined Company Operations Expected to be Funded Through Second Half of 2028","url":"https://stock-news.laohu8.com/highlight/detail?id=2652342794","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2652342794?lang=en_us&edition=fundamental","pubTime":"2026-07-17 05:15","pubTimestamp":1784236500,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260716:nTUAB2R19J:3","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["JSPR","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2652271464","title":"Jasper Therapeutics trading halted, news pending","url":"https://stock-news.laohu8.com/highlight/detail?id=2652271464","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2652271464?lang=en_us&edition=fundamental","pubTime":"2026-07-17 05:10","pubTimestamp":1784236211,"startTime":"0","endTime":"0","summary":"17:10 EDT Jasper Therapeutics (JSPR) trading halted, news pending Published first on TheFly – the ultimate source for real-time, market-moving brea...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/jasper-therapeutics-trading-halted-news-pending-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/jasper-therapeutics-trading-halted-news-pending-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4139","JSPR"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2652615427","title":"NASDAQ Trade Halt Halt News Pending at 05:10 Pm","url":"https://stock-news.laohu8.com/highlight/detail?id=2652615427","media":"Reuters","labels":["event"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2652615427?lang=en_us&edition=fundamental","pubTime":"2026-07-17 05:10","pubTimestamp":1784236200,"startTime":"0","endTime":"0","summary":"NASDAQ TRADE HALTHALT NEWS PENDING AT 05:10 PM","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260716:nAQN2M9FX5:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"event","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","JSPR"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2647556692","title":"Insider Traders Lose US$287k As Jasper Therapeutics Drops","url":"https://stock-news.laohu8.com/highlight/detail?id=2647556692","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2647556692?lang=en_us&edition=fundamental","pubTime":"2026-06-30 19:16","pubTimestamp":1782818217,"startTime":"0","endTime":"0","summary":"Insiders who bought US$347.5k worth of Jasper Therapeutics, Inc.'s ( NASDAQ:JSPR ) stock at an average buy price of...","market":"nz","thumbnail":"https://images.simplywall.st/asset/industry/6111000-choice1-main-header/1585186710114","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/6111000-choice1-main-header/1585186710114"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-jspr/jasper-therapeutics/news/insider-traders-lose-us287k-as-jasper-therapeutics-drops","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-jspr/jasper-therapeutics/news/insider-traders-lose-us287k-as-jasper-therapeutics-drops","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["JSPR","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2643333785","title":"Jasper Therapeutics announces annual shareholder meeting","url":"https://stock-news.laohu8.com/highlight/detail?id=2643333785","media":"Reuters","labels":["event"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2643333785?lang=en_us&edition=fundamental","pubTime":"2026-06-16 04:04","pubTimestamp":1781553871,"startTime":"0","endTime":"0","summary":"Jasper Therapeutics will hold its annual stockholders meeting virtually on July 31, 2026.Items up for a vote include electing two Class II directors to terms running to the 2029 annual meeting.An advisory vote on named executive officer compensation is also scheduled.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Jasper Therapeutics Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on June 15, 2026, and is solely responsible for the information contained therein.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260615:nNDL4CCf4N:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"event","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["JSPR","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2642349201","title":"Jasper Therapeutics -  on June 3, 2026, Co Receives Nasdaq Notice for Minimum Bid Price Non-Compliance - SEC Filing","url":"https://stock-news.laohu8.com/highlight/detail?id=2642349201","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2642349201?lang=en_us&edition=fundamental","pubTime":"2026-06-10 04:07","pubTimestamp":1781035671,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260609:nFWN42H0Q8:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["JSPR","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2642149202","title":"Jasper Therapeutics gets Nasdaq notice after shares trade below $1 bid-price minimum","url":"https://stock-news.laohu8.com/highlight/detail?id=2642149202","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2642149202?lang=en_us&edition=fundamental","pubTime":"2026-06-10 04:07","pubTimestamp":1781035639,"startTime":"0","endTime":"0","summary":"Jasper Therapeutics received a Nasdaq notice for failing the $1 minimum bid rule after 30 consecutive business days below $1.Granted 180 days to regain compliance by Nov. 30, 2026; compliance requires a closing bid of at least $1 for 10 straight sessions.Shares and public warrants continue trading on Nasdaq Capital Market under JSPR, JSPRW; no immediate impact on listing.Noncompliance by the deadline could trigger delisting risk; a second 180-day cure period may be available, potentially via reverse stock split.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Jasper Therapeutics Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260609:nNDL95L7Q0:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","JSPR"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2641126868","title":"Deal Dispatch: Jasper Therapeutics For Sale, RobinHood Completes $180 Million WonderFi Acquisition, Long John Silver's Franchisee To Liquidate","url":"https://stock-news.laohu8.com/highlight/detail?id=2641126868","media":"Benzinga","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2641126868?lang=en_us&edition=fundamental","pubTime":"2026-06-06 01:14","pubTimestamp":1780679640,"startTime":"0","endTime":"0","summary":"Major M&A deals this week include: New Mountail Capital buys Asset Living, SalesForce acquires Contentful, Wellington nabs The Hartford Funds","market":"sh","thumbnail":"https://cdn.benzinga.com/cdn-cgi/image/width=260,dpr=2,format=auto,quality=85/files/images/story/2026/06/05/benzinga-deal-dispatch2.jpeg","type":0,"news_type":0,"thumbnails":["https://cdn.benzinga.com/cdn-cgi/image/width=260,dpr=2,format=auto,quality=85/files/images/story/2026/06/05/benzinga-deal-dispatch2.jpeg"],"rights":{"source":"benzinga_hot_news","url":"https://www.benzinga.com/m-a/26/06/53036552/deal-dispatch-jasper-therapeutics-for-sale-robinhood-completes-180-million-wonderfi-acquisition-long-john-silvers-franchisee-to-liquidate","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.benzinga.com/m-a/26/06/53036552/deal-dispatch-jasper-therapeutics-for-sale-robinhood-completes-180-million-wonderfi-acquisition-long-john-silvers-franchisee-to-liquidate","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"benzinga_hot_news","symbols":["YMAG","SETM","HK0000532082.HKD","LU0068578508.USD","GOOG","TSLA","LU0208291251.USD","GGLL","LU0792757196.USD","SG9999000418.SGD","HK0000819398.USD","GOOX","AAPL","LU2456880835.USD","LU0784384876.USD","GOOGL","LU0444971666.USD","SG9999015945.SGD","SOCL","IE00B7KXQ091.USD","NVDA","LU0426412945.USD","META","JSPR","IE0004091025.USD","LU2462157665.USD","WTAI","GOOP","LU2125154935.USD","LU2764263039.SGD","GOOW","GGLS","LU0289961442.SGD","AMZN","LU0965508806.USD","LU0130102774.USD","LU2404859741.USD","LU0557290698.USD","IE000SO60NU8.SGD","USJW.SI","LU2237443978.SGD","GOU","MSFT","GOOY","LU0096364046.USD","MAGY","LU0820561818.USD","LU0661504455.SGD","LU0310799852.SGD","LU1116320901.HKD"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"websiteUrl":"http://www.jaspertherapeutics.com","stockEarnings":[{"period":"1week","weight":0.1262},{"period":"1month","weight":0.3787},{"period":"3month","weight":-0.234},{"period":"6month","weight":-0.4744},{"period":"1year","weight":-0.7401},{"period":"ytd","weight":-0.6123}],"compareEarnings":[{"period":"1week","weight":0.0351},{"period":"1month","weight":0.0374},{"period":"3month","weight":0.0483},{"period":"6month","weight":0.1197},{"period":"1year","weight":0.223},{"period":"ytd","weight":0.1339}],"compareStock":{"symbol":"SPY","name":"SPDR S&P 500 ETF Trust"},"description":"Jasper Therapeutics, Inc., a clinical-stage biotechnology company, develops therapeutic agents for hematopoietic stem cell transplantation and gene therapies. It focuses on the development and commercialization of therapeutic agents for diseases, such as chronic spontaneous urticaria, lower to intermediate risk myelodysplastic syndrome, and novel conditioning regimens for stem cell transplantation and ex-vivo gene therapy, a technique in which genetic manipulation of cells is performed outside of the body prior to transplantation. The company's lead product candidate is briquilimab, which is in clinical development as a novel therapeutic antibody that clears hematopoietic stem cells from bone marrow in patients prior to undergoing allogeneic stem cell therapy or stem cell gene therapy. It is also developing engineered hematopoietic stem cells product candidates to overcome key limitations of allogeneic and autologous gene-edited stem cell grafts. The company is headquartered in Redwood City, California.","yearOnYearQuotes":[{"month":1,"riseRate":0.5,"avgChangeRate":0.285776},{"month":2,"riseRate":0.428571,"avgChangeRate":0.093912},{"month":3,"riseRate":0.142857,"avgChangeRate":-0.063229},{"month":4,"riseRate":0.571429,"avgChangeRate":-0.031704},{"month":5,"riseRate":0.714286,"avgChangeRate":0.025166},{"month":6,"riseRate":0.428571,"avgChangeRate":-0.150942},{"month":7,"riseRate":0.285714,"avgChangeRate":-0.014598},{"month":8,"riseRate":0.571429,"avgChangeRate":0.011612},{"month":9,"riseRate":0.166667,"avgChangeRate":-0.2127},{"month":10,"riseRate":0.166667,"avgChangeRate":-0.027786},{"month":11,"riseRate":0.333333,"avgChangeRate":-0.069737},{"month":12,"riseRate":0.333333,"avgChangeRate":-0.008174}],"exchange":"NASDAQ","name":"Jasper Therapeutics","nameEN":"Jasper Therapeutics"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"isLaohu8Offline":false,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.47.1","shortVersion":"4.47.1","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Jasper Therapeutics(JSPR),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","description":"Find the latest Jasper Therapeutics(JSPR) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","keywords":"Jasper Therapeutics,JSPR,Jasper Therapeutics股票,Jasper Therapeutics股票老虎,Jasper Therapeutics股票老虎国际,Jasper Therapeutics行情,Jasper Therapeutics股票行情,Jasper Therapeutics股价,Jasper Therapeutics股市,Jasper Therapeutics股票价格,Jasper Therapeutics股票交易,Jasper Therapeutics股票购买,Jasper Therapeutics股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Jasper Therapeutics(JSPR),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","og_description":"Find the latest Jasper Therapeutics(JSPR) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","og_image":"https://community-static.tradeup.com/news/9b6dafd60190235ae8e2c95f52c583a0"}}}